Somi Health review
The seller states the flat-dose claim in its own capital letters, and prices its tablet at more than double the shot.
The verdict
Somi Health publishes $135 a month for injected semaglutide on a three-month plan and $165 for tirzepatide, read August 2026. Both cards say ANY DOSE. The tablet is $279.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Flat across doses
- Injection
- From $135/mo
- Oral
- From $279/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Somi Health sells both molecules by injection and semaglutide as a tablet. The injections are priced by plan length. The tablet has one published plan.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The pages price plans rather than describe care. No clinician is named.
Stating the dose claim in capitals is unusual and useful. It leaves no room to argue the figure was a starting rate.
What happens when the dose goes up?
ANY DOSE is the whole answer, given plainly on both injection cards. Nothing states what the tablet does at a higher strength.
What the price includes
Six months of injected semaglutide is $810 and tirzepatide $990, on the three-month plans. The tablet costs $279 a month, which is more than double the injection it replaces. Only the one-month tablet plan is published.
What it claims, and what it cites
All three lines are compounded. A pharmacy makes them to order. No agency reviews them before they ship.
Where it holds up, and where it does not
- Strength: The flat-dose claim is stated emphatically
- Strength: Both injections priced by plan length
- Strength: A tablet route exists and is priced
- Limitation: The tablet costs more than double the shot
- Limitation: Only one tablet plan is published
- Limitation: No milligram appears on any card
- Limitation: Nothing lists the states served
What the evidence says about this kind of treatment
The assessment above is about Somi Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants the dose question answered in writing before anything else.
- Wrong for
- A reader hoping the tablet is the cheaper way in here.
How Somi Health compares
| Seller | Who it suits | Go |
|---|---|---|
| Silhouette MD | Readers who want an unqualified number and will pay the tablet premium for one | See Silhouette MD → |
 Auren Rx | Readers who want tirzepatide without paying a premium for it | See Auren Rx → |
| Pepton Health | Readers who will create an account before deciding anything | See Pepton Health → |
More GLP-1 telehealth sellers reviews: YourHealthRxZera HealthBreeze MedsCare Bare RxCoreAge RxStrut Health
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Does the price change with the dose?
- No. Both injection cards say ANY DOSE, in the seller's own capitals.
- What does the tablet cost?
- $279 a month, on the only tablet plan published.
- What does six months come to?
- $810 for semaglutide and $990 for tirzepatide on the three-month plans.
- Is Somi Health expensive compared with other GLP-1 telehealth sellers?
- Somi Health publishes a starting figure of $135/mo. Across the 188 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts Somi Health below the median, toward the cheaper end. The other 12 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.